SCHEMBL22011198

SCHEMBL22011198

CCCCCc1ccc(-c2cc3oc4cc(CCC)c(F)c(F)c4c3c(F)c2F)c(F)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.35
KDM4E B2RXH2 4/20 0.31
MEN1 O00255 3/20 0.31
HTT P42858 3/20 0.31
KMT2A Q03164 3/20 0.31
LMNA P02545 2/20 0.31
POLB P06746 2/20 0.31
ALDH1A1 P00352 2/20 0.31
GAA P10253 2/20 0.31
ATM Q13315 1/20 0.31
MAPT P10636 3/20 0.31
APAF1 O14727 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
STAT6 P42226 1/20 0.31
HIF1A Q16665 1/20 0.31
USP2 O75604 1/20 0.31
ESR1 P03372 1/20 0.31
HPGD P15428 1/20 0.31
CACNA1B Q00975 1/20 0.31
APBA1 Q02410 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011234 0.86 CTSL (0.38) KDM4EMEN1HTTKMT2ALMNA
SCHEMBL22011800 0.80 HTT (0.37) KDM4EMEN1HTTKMT2ALMNA
SCHEMBL22011103 0.76 RARB (0.42) KDM4EMEN1KMT2ALMNAALDH1A1
SCHEMBL20828855 0.76 ALDH1A1 (0.40) KDM4EMEN1HTTKMT2APOLB
SCHEMBL22011795 0.75 ALDH1A1 (0.38) KDM4EMEN1HTTKMT2APOLB
SCHEMBL22010821 0.74 RARB (0.36) KDM4EMEN1HTTKMT2AALDH1A1
SCHEMBL22010983 0.73 ALDH1A1 (0.38) KDM4EHTTLMNAALDH1A1GAA
SCHEMBL22011802 0.72 CTSL (0.38) KDM4EMEN1HTTKMT2ALMNA
SCHEMBL22011819 0.71 S1PR1 (0.37) KDM4EMEN1HTTKMT2ALMNA
SCHEMBL22010799 0.69 PGAM1 (0.39) KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 KCNH2 1057/4885KDM4E 2962/4885MEN1 2633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.